Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Malignant Glioma.

This study has been completed.
Sponsor:
Collaborator:
Rhode Island Hospital
Information provided by:
Sigma-Tau Research, Inc.
ClinicalTrials.gov Identifier:
NCT00032903
First received: April 5, 2002
Last updated: June 2, 2009
Last verified: June 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2005
  Estimated Primary Completion Date: No date given